table of content
1 Introduction to Research & Analysis Reports
1.1 Tumor Immunity Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Immunity Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Immunity Therapy Overall Market Size
2.1 Global Tumor Immunity Therapy Market Size: 2022 VS 2030
2.2 Global Tumor Immunity Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor Immunity Therapy Players in Global Market
3.2 Top Global Tumor Immunity Therapy Companies Ranked by Revenue
3.3 Global Tumor Immunity Therapy Revenue by Companies
3.4 Top 3 and Top 5 Tumor Immunity Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tumor Immunity Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Immunity Therapy Players in Global Market
3.6.1 List of Global Tier 1 Tumor Immunity Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor Immunity Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Tumor Immunity Therapy Market Size Markets, 2022 & 2030
4.1.2 Immune Checkpoint Inhibitor
4.1.3 Cytokine Immunotherapy
4.1.4 Cancer Vaccine
4.1.5 Car-t Cell Therapy
4.1.6 Others
4.2 By Type - Global Tumor Immunity Therapy Revenue & Forecasts
4.2.1 By Type - Global Tumor Immunity Therapy Revenue, 2018-2023
4.2.2 By Type - Global Tumor Immunity Therapy Revenue, 2023-2030
4.2.3 By Type - Global Tumor Immunity Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor Immunity Therapy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Tumor Immunity Therapy Revenue & Forecasts
5.2.1 By Application - Global Tumor Immunity Therapy Revenue, 2018-2023
5.2.2 By Application - Global Tumor Immunity Therapy Revenue, 2023-2030
5.2.3 By Application - Global Tumor Immunity Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Tumor Immunity Therapy Market Size, 2022 & 2030
6.2 By Region - Global Tumor Immunity Therapy Revenue & Forecasts
6.2.1 By Region - Global Tumor Immunity Therapy Revenue, 2018-2023
6.2.2 By Region - Global Tumor Immunity Therapy Revenue, 2023-2030
6.2.3 By Region - Global Tumor Immunity Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Tumor Immunity Therapy Revenue, 2018-2030
6.3.2 US Tumor Immunity Therapy Market Size, 2018-2030
6.3.3 Canada Tumor Immunity Therapy Market Size, 2018-2030
6.3.4 Mexico Tumor Immunity Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Tumor Immunity Therapy Revenue, 2018-2030
6.4.2 Germany Tumor Immunity Therapy Market Size, 2018-2030
6.4.3 France Tumor Immunity Therapy Market Size, 2018-2030
6.4.4 U.K. Tumor Immunity Therapy Market Size, 2018-2030
6.4.5 Italy Tumor Immunity Therapy Market Size, 2018-2030
6.4.6 Russia Tumor Immunity Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Tumor Immunity Therapy Market Size, 2018-2030
6.4.8 Benelux Tumor Immunity Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Tumor Immunity Therapy Revenue, 2018-2030
6.5.2 China Tumor Immunity Therapy Market Size, 2018-2030
6.5.3 Japan Tumor Immunity Therapy Market Size, 2018-2030
6.5.4 South Korea Tumor Immunity Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Tumor Immunity Therapy Market Size, 2018-2030
6.5.6 India Tumor Immunity Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Tumor Immunity Therapy Revenue, 2018-2030
6.6.2 Brazil Tumor Immunity Therapy Market Size, 2018-2030
6.6.3 Argentina Tumor Immunity Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tumor Immunity Therapy Revenue, 2018-2030
6.7.2 Turkey Tumor Immunity Therapy Market Size, 2018-2030
6.7.3 Israel Tumor Immunity Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Tumor Immunity Therapy Market Size, 2018-2030
6.7.5 UAE Tumor Immunity Therapy Market Size, 2018-2030
7 Players Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporate Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Tumor Immunity Therapy Major Product Offerings
7.1.4 Bristol-Myers Squibb Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Key News
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Corporate Summary
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. Tumor Immunity Therapy Major Product Offerings
7.2.4 Merck & Co., Inc. Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.2.5 Merck & Co., Inc. Key News
7.3 Roche AG
7.3.1 Roche AG Corporate Summary
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Tumor Immunity Therapy Major Product Offerings
7.3.4 Roche AG Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.3.5 Roche AG Key News
7.4 AstraZeneca, Plc
7.4.1 AstraZeneca, Plc Corporate Summary
7.4.2 AstraZeneca, Plc Business Overview
7.4.3 AstraZeneca, Plc Tumor Immunity Therapy Major Product Offerings
7.4.4 AstraZeneca, Plc Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca, Plc Key News
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Corporate Summary
7.5.2 Sanofi S.A. Business Overview
7.5.3 Sanofi S.A. Tumor Immunity Therapy Major Product Offerings
7.5.4 Sanofi S.A. Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.5.5 Sanofi S.A. Key News
7.6 Dendreon Pharmaceuticals
7.6.1 Dendreon Pharmaceuticals Corporate Summary
7.6.2 Dendreon Pharmaceuticals Business Overview
7.6.3 Dendreon Pharmaceuticals Tumor Immunity Therapy Major Product Offerings
7.6.4 Dendreon Pharmaceuticals Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.6.5 Dendreon Pharmaceuticals Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Tumor Immunity Therapy Major Product Offerings
7.7.4 Novartis Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News
7.8 Gilead Sciences Inc.
7.8.1 Gilead Sciences Inc. Corporate Summary
7.8.2 Gilead Sciences Inc. Business Overview
7.8.3 Gilead Sciences Inc. Tumor Immunity Therapy Major Product Offerings
7.8.4 Gilead Sciences Inc. Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.8.5 Gilead Sciences Inc. Key News
7.9 IMVAQ Therapeutics
7.9.1 IMVAQ Therapeutics Corporate Summary
7.9.2 IMVAQ Therapeutics Business Overview
7.9.3 IMVAQ Therapeutics Tumor Immunity Therapy Major Product Offerings
7.9.4 IMVAQ Therapeutics Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.9.5 IMVAQ Therapeutics Key News
7.10 Arch Oncology
7.10.1 Arch Oncology Corporate Summary
7.10.2 Arch Oncology Business Overview
7.10.3 Arch Oncology Tumor Immunity Therapy Major Product Offerings
7.10.4 Arch Oncology Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.10.5 Arch Oncology Key News
7.11 Juno Therapeutics
7.11.1 Juno Therapeutics Corporate Summary
7.11.2 Juno Therapeutics Business Overview
7.11.3 Juno Therapeutics Tumor Immunity Therapy Major Product Offerings
7.11.4 Juno Therapeutics Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.11.5 Juno Therapeutics Key News
7.12 Refuge
7.12.1 Refuge Corporate Summary
7.12.2 Refuge Business Overview
7.12.3 Refuge Tumor Immunity Therapy Major Product Offerings
7.12.4 Refuge Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.12.5 Refuge Key News
7.13 Lepu Biopharma
7.13.1 Lepu Biopharma Corporate Summary
7.13.2 Lepu Biopharma Business Overview
7.13.3 Lepu Biopharma Tumor Immunity Therapy Major Product Offerings
7.13.4 Lepu Biopharma Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.13.5 Lepu Biopharma Key News
7.14 Genoimmune
7.14.1 Genoimmune Corporate Summary
7.14.2 Genoimmune Business Overview
7.14.3 Genoimmune Tumor Immunity Therapy Major Product Offerings
7.14.4 Genoimmune Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.14.5 Genoimmune Key News
7.15 TCR Cure
7.15.1 TCR Cure Corporate Summary
7.15.2 TCR Cure Business Overview
7.15.3 TCR Cure Tumor Immunity Therapy Major Product Offerings
7.15.4 TCR Cure Tumor Immunity Therapy Revenue in Global Market (2018-2023)
7.15.5 TCR Cure Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
